Latest market price
26.52
+0.23+0.87%
OverviewShort InterestFilings
STOKQT25Stoke Therapeutics, Inc.·NASDAQ
26.52+0.87%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 29, 20268-KCurrent report
Oct 02, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Sep 30, 2026SC 13GBeneficial ownership statement (passive)
Sep 25, 20264Statement of changes in beneficial ownership
Sep 25, 20268-KCurrent report
Sep 25, 20263Initial statement of beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 05, 20264Statement of changes in beneficial ownership
Aug 03, 20268-KCurrent report
Aug 03, 20268-KCurrent report
Aug 03, 202610-QQuarterly report
Aug 03, 2026S-8Registration of employee benefit securities
Aug 03, 2026424B5Prospectus
Jul 17, 20263Initial statement of beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 30, 20268-KCurrent report
#1 / 25 of 404
Page
▼
/ 17